Pilot Study on Auricular Acupuncture in Hospitalized Adults With Borderline Personality Disorder

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorJenny Gentizon

About this trial

The goal of this pilot study is to evaluate the feasibility and preliminary effectiveness of a brief auricular acupuncture program delivered by mental health nurses as a complementary therapy for adults hospitalized with borderline personality disorder (BPD). The main questions it aims to answer are:

* Is participation in the five-session auricular acupuncture program feasible (in terms of attendance) for hospitalized adults with borderline personality disorder? * Does the auricular acupuncture intervention show potential benefits on emotional regulation, anxiety, sleep quality, and overall clinical status?

15 hospitalized adults with BPD will receive 5 individual ear acupuncture sessions, over a 9-day period, based on the National Acupuncture Detoxification Association (N.A.D.A.) protocol in addition to treatment as usual. Participants will complete brief questionnaires at several time points. The findings will inform the feasibility of the study procedures and guide the development of a future larger-scale clinical trial.

Eligibility criteria

Qualifiers

Aged 18 years or older

Currently hospitalized in a psychiatric unit at the Prangins site of Lausanne University Hospital (CHUV)

Diagnosed with borderline personality disorder, as documented in the medical record

Able to speak and understand French

Disqualifiers

Presence of severe clinical instability, such as: marked agitation, high risk of suicide, risk of harm to others

Inability to provide informed consent (for example, due to impaired judgment or legal protective measures)

Currently hospitalized in a seclusion or isolation room

Expected discharge from hospital before completion of the five acupuncture sessions

Trial design

Treatments tested in this trial

  • Auricular acupuncture program based on the N.A.D.A. protocol

Treatment groups

15 Participants
are divided into 1 treatment group

Sponsors and collaborators

Jenny Gentizon

Lead sponsor

University of Lausanne Hospitals

Sponsor institution

Manuel Simon

Collaborator

Julien Elowe

Collaborator

Luca Scuderi

Collaborator